Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Alfacell Corporation (OTC BB:ACEL.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider | Financials
Recent Events
Aug 29Price hit new 52-week low ($0.46)
Location
225 Belleville Avenue
Bloomfield, NJ 07003
Phone: (973) 748-8082
Fax: (973) 748-8901
Email: investorinfo@alfacell.com
Employees (last reported count): 14
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 18%
·Over the last 6 months:
 · one insider sell; 56.0K shares
  (1.6% of insider shares)
·Institutional: 1% (1% of float)
(2 institutions)
·Net Inst. Buying: 16.0K shares (+11.76%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Alfacell Corporation is a development stage company engaged in the discovery, investigation and development of a new class of anti-cancer drugs from amphibian ribonucleases. Ribonucleases degrade ribonucleic acids causing an interruption in protein synthesis resulting in the inhibition of cell growth and induction of apoptosis (programmed cell death). Its first product under development is ONCONASE, which targets a variety of cancers, most of which are known to become resistant to other chemotherapeutic drugs.
More from Market Guide: Expanded Business Description

Financial Summary
Alfacell Corporation is a development stage biopharmaceutical company primarily engaged in the discovery and development of a new class of anti-cancer drugs from amphibian ribonucleases. For the nine months ended 4/30/01, revenues fell 79% to $8 thousand. Net loss rose 7% to $1.5 million. Revenues reflect lower balances of cash and cash equivalents. Higher loss reflects higher general, administrative and interest expenses and a decrease of $304 thousand in tax benefits.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Kuslima Shogen, 55
CEO, Chairman and Acting Chief Financial Officer
$154K
Stanislaw Mikulski, M.D., 56
Exec. VP and Medical Director
134K
Dollar amounts are as of 31-July-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ACEL.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Aug-2001
$0.46 
Recent Price$0.62 
52-Week High
on 15-Feb-2001
$2.188
Beta-0.58 
Daily Volume (3-month avg)30.4K
Daily Volume (10-day avg)64.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-47.8%
52-Week Change
relative to S&P500
-30.0%
Share-Related Items
Market Capitalization$11.7M
Shares Outstanding18.9M
Float15.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.03 
Earnings (ttm)-$0.10 
Earnings (mrq)-$0.04 
Sales (ttm)$0.00 
Cash (mrq)$0.02 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)579.98 
Income Statements
Sales (ttm)$20.0K
EBITDA (ttm)-$2.14M
Income available to common (ttm)-$1.81M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJuly 31
Most recent quarter30-Apr-2001
Management Effectiveness
Return on Assets (ttm)-259.43%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.36 
Debt/EquityN/A 
Total Cash (mrq)$360.0K
Short Interest
As of 10-May-1999
Shares Short0 
Shares Short
(Prior Month)
3,000 
Daily Volume35.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.